OL
KRYS icon

Odyssean LLC’s Krystal Biotech KRYS Stock Holding History

Odyssean LLC’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.47M Buy
9,349
+4,530
+94% +$1.35M 0.57% 10
2026
Q1 		$1.24M Buy
4,819
+1,805
+60% +$480K 0.45% 86
2025
Q4 		$743K Buy
+3,014
New +$634K 0.53% 62

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Odyssean LLC's KRYS Position: Q2 2026 in Review

Odyssean LLC increased its Krystal Biotech (KRYS) stake by 94% in Q2 2026, buying an estimated $1.35M and bringing the position to 9,349 shares worth $3.47M. The position accounts for 0.57% of the portfolio, ranked #10.

Odyssean LLC first reported a position in KRYS in Q4 2025 and has held it in 3 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Odyssean LLC held 9,349 shares of Krystal Biotech worth $3.47M as of Q2 2026.
  • Odyssean LLC bought 4,530 Krystal Biotech shares in Q2 2026, an estimated $1.35M.
  • Krystal Biotech made up 0.57% of Odyssean LLC's portfolio in Q2 2026, its #10 holding.
  • Odyssean LLC first reported a position in Krystal Biotech in Q4 2025 and has held it in 3 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.